Search research articles
Contact Us
Filters
Showing results (581-590 of 601) with videos related to
Page
of 61
Sort By:
British Journal of Cancer
|
April 11, 2013
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V Damiano, R Rosa, L Formisano, et al.
Human Gene Therapy
|
July 29, 1998
Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
M Laitinen, K Mäkinen, H Manninen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 19, 2017
Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors
X Zhao, S Suryawanshi, M Hruska, et al.
Experimental Hematology
|
July 2, 1999
Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas
L Chaperot, M H Delfau-Larue, M C Jacob, et al.
International Journal of Clinical Pediatric Dentistry
|
November 26, 2021
Comparative Evaluation of the Effectiveness of Different Pain-alleviating Methods before Local Anesthetic Administration in Children of 6 to 12 Years of Age: A Clinical Study
Sudha B Patil, Divya D Popali, Prashant A Bondarde, et al.
International Journal of Oncology
|
April 11, 2001
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides
S Agrawal, E R Kandimalla, D Yu, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
January 6, 2005
Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective
R Panchagnula, S Agrawal, Y Ashokraj, et al.
Molecular Metabolism
|
October 1, 2016
Fibroblast activation protein (FAP) as a novel metabolic target
Miguel Angel Sánchez-Garrido, Kirk M Habegger, Christoffer Clemmensen, et al.
Public Health Genomics
|
May 21, 2026
Sex-Based Disparities in Fabry Disease Cause Challenges in Newborn Screening
Yutaka Furuta, Neena S Agrawal, Natalie N Owen, et al.
Public Health Genomics
|
February 17, 2026
Sex-Specific Diagnostic Inequality in Fabry Disease: Lessons Learned from Analysis of Newborn Screening and Cascade Testing in Tennessee from 2017 to 2024
Yutaka Furuta, Neena S Agrawal, Natalie N Owen, et al.
Page
of 61
Search research articles
Search
Showing results (581-590 of 601) with videos related to
Sort By:
Page
of 61
British Journal of Cancer
|
April 11, 2013
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V Damiano, R Rosa, L Formisano, et al.
Human Gene Therapy
|
July 29, 1998
Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
M Laitinen, K Mäkinen, H Manninen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 19, 2017
Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors
X Zhao, S Suryawanshi, M Hruska, et al.
Experimental Hematology
|
July 2, 1999
Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas
L Chaperot, M H Delfau-Larue, M C Jacob, et al.
International Journal of Clinical Pediatric Dentistry
|
November 26, 2021
Comparative Evaluation of the Effectiveness of Different Pain-alleviating Methods before Local Anesthetic Administration in Children of 6 to 12 Years of Age: A Clinical Study
Sudha B Patil, Divya D Popali, Prashant A Bondarde, et al.
International Journal of Oncology
|
April 11, 2001
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides
S Agrawal, E R Kandimalla, D Yu, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
January 6, 2005
Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective
R Panchagnula, S Agrawal, Y Ashokraj, et al.
Molecular Metabolism
|
October 1, 2016
Fibroblast activation protein (FAP) as a novel metabolic target
Miguel Angel Sánchez-Garrido, Kirk M Habegger, Christoffer Clemmensen, et al.
Public Health Genomics
|
May 21, 2026
Sex-Based Disparities in Fabry Disease Cause Challenges in Newborn Screening
Yutaka Furuta, Neena S Agrawal, Natalie N Owen, et al.
Public Health Genomics
|
February 17, 2026
Sex-Specific Diagnostic Inequality in Fabry Disease: Lessons Learned from Analysis of Newborn Screening and Cascade Testing in Tennessee from 2017 to 2024
Yutaka Furuta, Neena S Agrawal, Natalie N Owen, et al.
Page
of 61